Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patupilone in recurrent glioblastoma multiforme
NCT00715013Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Jul 2008
- Primary completion
- Dec 2010
- Modality
- Covalent Small Molecules, RNA-Targeting Small Molecules, Classical Binding Small Molecules
01
Overview
A Phase 2 trial of patupilone in glioblastoma multiforme (GBM), sponsored by University of Zurich. Started Jul 2008; status: completed.
02
Drugs
patupilone
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00715013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00715013.